322 related articles for article (PubMed ID: 15935515)
1. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic tumor microenvironment in advanced retinoblastoma.
Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
[TBL] [Abstract][Full Text] [Related]
9. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
[TBL] [Abstract][Full Text] [Related]
10. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
12. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
14. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
[TBL] [Abstract][Full Text] [Related]
15. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
17. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
[TBL] [Abstract][Full Text] [Related]
18. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
19. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]